Skip to main content
logo
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.17
-0.15 (-1.61%)
At close: Jul 24, 2026, 4:00 PM EDT
9.18
+0.01 (0.11%)
After-hours: Jul 24, 2026, 7:34 PM EDT

CRBP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.88
Revenue Growth
------77.61%
Gross Profit
-----0.88
Operating Income
-89.84-85.31-48.72-45.08-39.84-55.99
Net Income
-84.53-78.54-40.21-44.6-42.35-45.64
Earnings Per Share
-5.82-5.90-3.68-10.31-10.15-11.15
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
138.22163.27149.0620.9159.297.65
Total Debt
1.211.633.2420.8925.0926.59
Net Cash (Debt)
137.01161.64145.820.0234.1171.06
Net Cash Growth
5.45%10.84%694295.24%-99.94%-52.00%21.26%
Net Cash Per Share
0.0412.1413.360.008.1817.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-73.64-64.49-41.79-36.1-37.54-48.18
Capital Expenditures
--0.01---0.01-0.05
Free Cash Flow
-73.64-64.5-41.79-36.1-37.56-48.24
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------6350.09%
Pretax Margin
------3795.07%
Profit Margin
------5176.38%
FCF Margin
------5470.98%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----87.49